BioNTech SE (BNTX) Change in Receivables (2020 - 2025)

BioNTech SE (BNTX) has 6 years of Change in Receivables data on file, last reported at $94.3 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Receivables rose 110.03% year-over-year to $94.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 billion (up 196.13% YoY), and the FY2025 full-year result was $1.2 billion, up 195.53% from the prior year.
• Change in Receivables slipped to $94.3 million in Q4 2025, from $1.0 billion in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $4.5 billion in Q2 2023 to a low of -$11.9 billion in Q3 2021.
• A 5-year average of -$372.7 million and a median of $47.1 million in 2021 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables slumped 851445957.2% in 2021 and soared 311.84% in 2023, its largest moves.
• Tracing BNTX's Change in Receivables over 5 years: stood at -$2.0 billion in 2021, then soared by 66.32% to -$659.9 million in 2022, then soared by 53.04% to -$309.9 million in 2023, then plunged by 203.44% to -$940.3 million in 2024, then soared by 110.03% to $94.3 million in 2025.
• Business Quant data shows BNTX's Change in Receivables at $94.3 million in Q4 2025, $1.0 billion in Q3 2025, and -$453.2 million in Q2 2025.